While the DAX year-to-date has clearly outperformed most of the large European and US indexes (except the IBEX), many corporates presenting at the 16th edition of our Corporate Conference, hosted jointly by ODDO BHF and Commerzbank, were still focused on the macroeconomic environment, geopolitical tensions and tariffs and the related impact on their sectors. Unsurprisingly, the clearly most positive sector was defence. For others, the picture was more mixed inside the sectors. Based on the feedb...
ODDO BHF and Commerzbank are jointly hosting the 16th edition of the Corporate Conference on 3 and 4 of September 2025 in Frankfurt am Main. This year, we are welcoming 88 German small, mid and large cap companies. Among the companies which presented during the first day, we highlight, notably, positive feedback from Adesso, BASF, Befesa, Commerzbank, Fresenius Medical Care, Fresenius SE, Fuchs, Hannover RE, Hensoldt, Implenia, Sartorius, Schott Pharma, Tonies and Zalando ADESSO (+) - Positive ...
Q3/25 wurde durch negative FX-Effekte und US-Zölle gedämpft (YoY in CC: Q3-Umsatz/ Q3-EBITA: +3,5 %/ +9 %), die Vollkonsolidierung DORC unterstützte das Volumenwachstum - die adj. Marge stieg YoY um 50 BP auf 7,7 %. Die Orderdynamik, und damit die Produktionsreichweite, nahm jüngst zu. Das 9M/25-adj. EPS erreichte € 1,24 (9M/24: € 1,35).
Q3/25 was dampened by negative FX effects and US tariffs (YoY in CC: Q3 revenue/Q3 EBITA: +3.5%/+9%), the full consolidation of DORC supported volume growth - the adjusted margin increased by 50 BP YoY to 7.7%. Order dynamics, and thus production capacity, have recently increased. The 9M/25 adjusted EPS reached €1.24 (9M/24: €1.35).
Surprisingly, Dr. Markus Weber, who has been CEO since 01.01.22, will hand over his office to Maximilian Foerst, who has been with ZEISS since 1995 and is currently Head of ZEISS Greater China, on 31.05.25. The handover will take place at Dr. Weber's own request and "in the best agreement with the Supervisory Board". In our opinion, greater attention will be paid to sales in the future, which will support the upcoming product launches and thus secure the targeted topline impulse. CFO Justus Feli...
Überraschend wird Dr. Markus Weber, der seit 01.01.22 CEO ist, sein Amt zum 31. 05.25 an Maximilian Foerst, seit 1995 bei ZEISS und derzeit Head of ZEISS Greater China, übergeben. Die Übergabe geschieht auf eigenen Wunsch von Dr. Weber und „im besten Einvernehmen mit dem Aufsichtsrat“. U.E. wird dem Vertrieb künftig eine größere Aufmerksamkeit zuteil, was die anstehenden Produkteinführungen unterstützt und so den anvisierten Topline-Impuls absichern soll. Der CFO Justus Felix Wehmer bleibt im Am...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.